These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19145210)

  • 21. New aspects in assessment of changes in width of subarachnoid space with near-infrared transillumination/backscattering sounding, part 1: Monte Carlo numerical modeling.
    Pluciński J; Frydrychowski AF
    J Biomed Opt; 2007; 12(4):044015. PubMed ID: 17867819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive side effects of brief pulse electroconvulsive therapy: a review.
    Ingram A; Saling MM; Schweitzer I
    J ECT; 2008 Mar; 24(1):3-9. PubMed ID: 18379328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New aspects in assessment of changes in width of subarachnoid space with near-infrared transillumination-backscattering sounding, part 2: clinical verification in the patient.
    Frydrychowski AF; Pluciński J
    J Biomed Opt; 2007; 12(4):044016. PubMed ID: 17867820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Asystole during electroconvulsive therapy].
    Hase K; Yoshioka H; Nakamura T; Kamei T; Isse K; Nakamura M
    Masui; 2005 Nov; 54(11):1268-72. PubMed ID: 16296366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of remifentanil on convulsion duration and hemodynamic responses during electroconvulsive therapy: a double-blind, randomized clinical trial.
    Nasseri K; Arasteh MT; Maroufi A; Shami S
    J ECT; 2009 Sep; 25(3):170-3. PubMed ID: 19755938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electroconvulsive therapy in a patient with a cavernous hemangioma.
    Stewart JT; Long WG
    J ECT; 2008 Dec; 24(4):292. PubMed ID: 18562947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycopyrrolate prevents extreme bradycardia and cerebral deoxygenation during electroconvulsive therapy.
    Rasmussen P; Andersson JE; Koch P; Secher NH; Quistorff B
    J ECT; 2007 Sep; 23(3):147-52. PubMed ID: 17804987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Near-infrared spectroscopy in carotid artery stenting predicts cerebral hyperperfusion syndrome.
    Matsumoto S; Nakahara I; Higashi T; Iwamuro Y; Watanabe Y; Takahashi K; Ando M; Takezawa M; Kira JI
    Neurology; 2009 Apr; 72(17):1512-8. PubMed ID: 19398706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monitoring of cognitive effects during a course of electroconvulsive therapy: recommendations for clinical practice.
    Porter RJ; Douglas K; Knight RG
    J ECT; 2008 Mar; 24(1):25-34. PubMed ID: 18379332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strategies to minimize cognitive side effects with ECT: aspects of ECT technique.
    Prudic J
    J ECT; 2008 Mar; 24(1):46-51. PubMed ID: 18379335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultra-brief pulse ECT in bipolar and unipolar depressive disorder: differences in speed of response.
    Sienaert P; Vansteelandt K; Demyttenaere K; Peuskens J
    Bipolar Disord; 2009 Jun; 11(4):418-24. PubMed ID: 19500095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microscope-integrated near-infrared indocyanine green videoangiography during surgery of intracranial aneurysms: the Helsinki experience.
    Dashti R; Laakso A; Niemelä M; Porras M; Hernesniemi J
    Surg Neurol; 2009 May; 71(5):543-50; discussion 550. PubMed ID: 19328531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum brain-derived neurotrophic factor (BDNF) is not associated with response to electroconvulsive therapy (ECT): a pilot study in drug resistant depressed patients.
    Fernandes B; Gama CS; Massuda R; Torres M; Camargo D; Kunz M; Belmonte-de-Abreu PS; Kapczinski F; de Almeida Fleck MP; Inês Lobato M
    Neurosci Lett; 2009 Apr; 453(3):195-8. PubMed ID: 19429034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Should electroconvulsive therapy be given to patients with intracranial vascular lesions?
    Meyer F; Chang T; Sewell RA; Price BH; Cunningham M
    Rev Neurol Dis; 2007; 4(1):43-50. PubMed ID: 17514158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cognitive effects of ECT: bridging the gap between research and clinical practice.
    Kellner CH
    Convuls Ther; 1996 Sep; 12(3):133-5. PubMed ID: 8872399
    [No Abstract]   [Full Text] [Related]  

  • 36. [Relapse rate within 6 months after successful ECT: a naturalistic prospective peer- and self-assessment analysis].
    Rehor G; Conca A; Schlotter W; Vonthein R; Bork S; Bode R; Hüll M; Plewnia C; Di Pauli J; Prapotnik M; Peters O; Peters J; Eschweiler GW
    Neuropsychiatr; 2009; 23(3):157-63. PubMed ID: 19703381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cognitive side effects of modern ECT: patient experience or objective measurement?
    Vamos M
    J ECT; 2008 Mar; 24(1):18-24. PubMed ID: 18379330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-lived response of cervical dystonia to electroconvulsive therapy.
    Garcia RF; Dias AG; de Freitas AR; Fontenelle LF
    J ECT; 2009 Jun; 25(2):135-6. PubMed ID: 19145211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurobiological correlates of the cognitive side effects of electroconvulsive therapy.
    Nobler MS; Sackeim HA
    J ECT; 2008 Mar; 24(1):40-5. PubMed ID: 18379334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive impairment following electroconvulsive therapy--does the choice of anesthetic agent make a difference?
    MacPherson RD; Loo CK
    J ECT; 2008 Mar; 24(1):52-6. PubMed ID: 18379336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.